SEC Form 4 · accession 0001354488-15-004031
Cellular Biomedicine Group, Inc. · CBMG
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Yihong Yao
Officer — Chief Scientific Officer
Period of report
Aug 4, 2015
Accepted (ET)
Aug 21, 2015 · 5:19 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001378624
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock | Aug 4, 2015 | A | 25,000 | $0.00 | A | 25,500 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Incentive Stock Option | $26.53 | Aug 4, 2015 | A | 25,000 | A | Aug 4, 2016 | Aug 4, 2025 | Common Stock | 25,000 | 25,000 | D |